ICeD-T Provides Accurate Estimates of Immune Cell Abundance in Tumor Samples by Allowing for Aberrant Gene Expression Patterns

References

• Angelova, M., Charoentong, P., Hackl, H., Fischer, M. L., Snajder, R., Krogsdam, A. M., Waldner, M. J., Bindea, G., Mlecnik, B., Galon, J., and Trajanoski, Z. (2015), “Characterization of the Immunophenotypes and Antigenomes of Colorectal Cancers Reveals Distinct Tumor Escape Mechanisms and Novel Targets for Immunotherapy,” Genome Biology, 16, 64. DOI:10.1186/s13059-015-0620-6.
   PubMed Web of Science ®Google Scholar
• Angerer, P., Simon, L., Tritschler, S., Wolf, F. A., Fischer, D., and Theis, F. J. (2017), “Single Cells Make Big Data: New Challenges and Opportunities in Transcriptomics,” Current Opinion in Systems Biology, 4, 85–91. DOI:10.1016/j.coisb.2017.07.004.
   Google Scholar
• Becht, E., Giraldo, N. A., Lacroix, L., Buttard, B., Elarouci, N., Petitprez, F., Selves, J., Laurent-Puig, P., Sautès-Fridman, C., Fridman, W. H., and De Reyniès, A. (2016), “Estimating the Population Abundance of Tissue-Infiltrating Immune and Stromal Cell Populations Using Gene Expression,” Genome Biology, 17, 218. DOI:10.1186/s13059-016-1070-5.
   PubMed Web of Science ®Google Scholar
• Bewick, V., Cheek, L., and Ball, J. (2004), “Statistics Review 10: Further Nonparametric Methods,” Critical Care, 8, 196–199. DOI:10.1186/cc2857.
   PubMedGoogle Scholar
• Bindea, G., Mlecnik, B., Tosolini, M., Kirilovsky, A., Waldner, M., Obenauf, A. C., Angell, H., Fredriksen, T., Lafontaine, L., Berger, A., and Bruneval, P. (2013), “Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer,” Immunity, 39, 782–795. DOI:10.1016/j.immuni.2013.10.003.
   PubMed Web of Science ®Google Scholar
• Brown, S. D., Warren, R. L., Gibb, E. A., Martin, S. D., Spinelli, J. J., Nelson, B. H., and Holt, R. A. (2014), “Neo-Antigens Predicted by Tumor Genome Meta-Analysis Correlate With Increased Patient Survival,” Genome Research, 24, 743–750. DOI:10.1101/gr.165985.113.
   PubMed Web of Science ®Google Scholar
• Carter, S. L., Cibulskis, K., Helman, E., McKenna, A., Shen, H., Zack, T., Laird, P. W., Onofrio, R. C., Winckler, W., Weir, B. A., and Beroukhim, R. (2012), “Absolute Quantification of Somatic DNA Alterations in Human Cancer,” Nature Biotechnology, 30, 413–421. DOI:10.1038/nbt.2203.
   PubMed Web of Science ®Google Scholar
• Chen, D. S., and Mellman, I. (2017), “Elements of Cancer Immunity and the Cancer–Immune Set Point,” Nature, 541, 321. DOI:10.1038/nature21349.
   PubMed Web of Science ®Google Scholar
• Dunn, G. P., Koebel, C. M., and Schreiber, R. D. (2006), “Interferons, Immunity and Cancer Immunoediting,” Nature Reviews Immunology, 6, 836. DOI:10.1038/nri1961.
   PubMed Web of Science ®Google Scholar
• Farkona, S., Diamandis, E. P., and Blasutig, I. M. (2016), “Cancer Immunotherapy: The Beginning of the End of Cancer?,” BMC Medicine, 14, 73. DOI:10.1186/s12916-016-0623-5.
   PubMed Web of Science ®Google Scholar
• Fenton, L. (1960), “The Sum of Log-Normal Probability Distributions in Scatter Transmission Systems,” IRE Transactions on Communications Systems, 8, 57–67. DOI:10.1109/TCOM.1960.1097606.
   Google Scholar
• Gierliński, M., Cole, C., Schofield, P., Schurch, N. J., Sherstnev, A., Singh, V., Wrobel, N., Gharbi, K., Simpson, G., Owen-Hughes, T., and Blaxter, M. (2015), “Statistical Models for RNA-Seq Data Derived From a Two-Condition 48-Replicate Experiment,” Bioinformatics, 31, 3625–3630. DOI:10.1093/bioinformatics/btv425.
   PubMed Web of Science ®Google Scholar
• Hugo, W., Zaretsky, J. M., Sun, L., Song, C., Moreno, B. H., Hu-Lieskovan, S., Berent-Maoz, B., Pang, J., Chmielowski, B., Cherry, G., and Seja, E. (2016), “Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma,” Cell, 165, 35–44. DOI:10.1016/j.cell.2016.02.065.
   PubMed Web of Science ®Google Scholar
• Law, C. W., Chen, Y., Shi, W., and Smyth, G. K. (2014), “voom: Precision Weights Unlock Linear Model Analysis Tools for RNA-Seq Read Counts,” Genome Biology, 15, R29. DOI:10.1186/gb-2014-15-2-r29.
   PubMed Web of Science ®Google Scholar
• Li, B., Severson, E., Pignon, J.-C., Zhao, H., Li, T., Novak, J., Jiang, P., Shen, H., Aster, J. C., Rodig, S., and Signoretti, S. (2016), “Comprehensive Analyses of Tumor Immunity: Implications for Cancer Immunotherapy,” Genome Biology, 17, 174. DOI:10.1186/s13059-016-1028-7.
   PubMed Web of Science ®Google Scholar
• Linsley, P. S., Speake, C., Whalen, E., and Chaussabel, D. (2014), “Copy Number Loss of the Interferon Gene Cluster in Melanomas Is Linked to Reduced T Cell Infiltrate and Poor Patient Prognosis,” PLoS One, 9, e109760. DOI:10.1371/journal.pone.0109760.
   PubMed Web of Science ®Google Scholar
• Newman, A. M., Liu, C. L., Green, M. R., Gentles, A. J., Feng, W., Xu, Y., Hoang, C. D., Diehn, M., and Alizadeh, A. A. (2015), “Robust Enumeration of Cell Subsets From Tissue Expression Profiles,” Nature Methods, 12, 453–457. DOI:10.1038/nmeth.3337.
   PubMed Web of Science ®Google Scholar
• Racle, J., deJonge, K., Baumgaertner, P., Speiser, D. E., and Gfeller, D. (2017), “Simultaneous Enumeration of Cancer and Immune Cell Types From Bulk Tumor Gene Expression Data,” Elife, 6, e26476. DOI:10.7554/eLife.26476.
   PubMed Web of Science ®Google Scholar
• Rooney, M. S., Shukla, S. A., Wu, C. J., Getz, G., and Hacohen, N. (2015), “Molecular and Genetic Properties of Tumors Associated With Local Immune Cytolytic Activity,” Cell, 160, 48–61. DOI:10.1016/j.cell.2014.12.033.
   PubMed Web of Science ®Google Scholar
• Sato, E., Olson, S. H., Ahn, J., Bundy, B., Nishikawa, H., Qian, F., Jungbluth, A. A., Frosina, D., Gnjatic, S., Ambrosone, C., and Kepner, J. (2005), “Intraepithelial CD8+ Tumor-Infiltrating Lymphocytes and a High CD8+/Regulatory T Cell Ratio Are Associated With Favorable Prognosis in Ovarian Cancer,” Proceedings of the National Academy of Sciences of the United States of America, 102, 18538–18543. DOI:10.1073/pnas.0509182102.
   PubMed Web of Science ®Google Scholar
• Schreiber, R. D., Old, L. J., and Smyth, M. J. (2011), “Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion,” Science, 331, 1565–1570. DOI:10.1126/science.1203486.
   PubMed Web of Science ®Google Scholar
• Sharma, P., and Allison, J. P. (2015), “The Future of Immune Checkpoint Therapy,” Science, 348, 56–61. DOI:10.1126/science.aaa8172.
   PubMed Web of Science ®Google Scholar
• Topalian, S. L., Taube, J. M., Anders, R. A., and Pardoll, D. M. (2016), “Mechanism-Driven Biomarkers to Guide Immune Checkpoint Blockade in Cancer Therapy,” Nature Reviews Cancer, 16, 275. DOI:10.1038/nrc.2016.36.
   PubMed Web of Science ®Google Scholar
• Van Loo, P., et al. (2010), “Allele-specific copy number analysis of tumors.” Proceedings of the National Academy of Science. Vol. 107.
   Google Scholar
• Yarchoan, M., Hopkins, A., and Jaffee, E. M. (2017), “Tumor Mutational Burden and Response Rate to PD-1 Inhibition,” New England Journal of Medicine, 377, 2500–2501. DOI:10.1056/NEJMc1713444.
   PubMed Web of Science ®Google Scholar
• Zhong, Y., and Liu, Z. (2012), “Gene Expression Deconvolution in Linear Space,” Nature Methods, 9, 8–9. DOI:10.1038/nmeth.1830.
   Web of Science ®Google Scholar